Tennessee SB0282 establishes the Individualized Investigational Treatment Act, allowing patients with life-threatening or severely debilitating.
Tennessee SB0282, known as the Individualized Investigational Treatment Act, allows patients with life-threatening or severely debilitating illnesses to access personalized treatments. Eligible patients must meet specific criteria, including having a condition that is unlikely to be treated effectively by currently approved methods. The act permits manufacturers and facilities to provide these treatments without compensation and requires patients to provide informed consent.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.